- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Digirad wins solid-state detector patent
Solid-state gamma camera developer Digirad of San Diego announced this month that the U.S. Patent Office has granted the company a patent on a method of manufacturing solid-state digital detector modules. Digirad believes the patent is so comprehensive
Solid-state gamma camera developer Digirad of San Diego announced this month that the U.S. Patent Office has granted the company a patent on a method of manufacturing solid-state digital detector modules. Digirad believes the patent is so comprehensive that it will be difficult for other potential solid-state detector manufacturers to avoid infringement.
The patent covers technology that uses semiconductor gamma ray detector modules that can be butted on all sides to form a seamless imaging array of any size. The patent also covers gamma cameras that use these modules, according to the company.
Digirad is unaware of any commercially feasible way to manufacture a solid-state, large field-of-view gamma camera without violating the patent, because solid-state cameras require individual detectors that must be tiled together, rather than a single crystal as used in vacuum-tube systems, according to Karen Klause, president and CEO. Klause declined to comment on whether Digirad would license the buttable module technology.
Digirad manufactures and markets Digirad 2020 TC Imager, a portable single-head gamma camera that uses solid-state detector technology.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
